secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2022-01-04T23:59:59+00:00
Accession:  0001193125-22-001024
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen promotes James Bylund to Chief Operating Officer effective Jan 1, 2022
-------------------------------------------------------------------------------

- James Bylund promoted from SVP, Operations & IT to COO and principal operating officer, effective Jan 1, 2022.
- Bylund joined Repligen in March 2020; prior 10 years at Thermo Fisher as VP & GM of Single Use Technologies.
- He also held leadership roles at Fiserv (9 years) and Eli Lilly (7 years); holds B.S. from Utah State and MBA from Indiana.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312522001024/0001193125-22-001024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312522001024/d245127d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-001024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer